Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine Injection for Hypertensive Emergencies and Urgencies
CTR20210819Phase 3Completed
- Sponsor
- Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences, People's Liberation Army of China
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clevidipine in hypertensive emergency, hypertensive urgency, resistant hypertension (RH), sponsored by Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences, People's Liberation Army of China. Started May 2021; status: completed.
02
Drugs
clevidipine
03
Conditions
hypertensive emergencyhypertensive urgencyresistant hypertension (RH)
Beyond the preview
Go deeper on CTR20210819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210819.